mhurhangee/patent-ind-claim-en huggingface dataset:
A machine , configured to remove and mount a tyre from and on a respective rim of a vehicle wheel , comprising an operating arm directed along a longitudinal orientation, the operating arm including: - a head supported by the operating arm ; - a first tool and a second tool ; - the first tool is connected to the head and projects in a first direction, the first direction being directed along an orientation transverse to the longitudinal orientation; - the second tool is connected to the head and, in a first operating configuration of the head , is disposed in a first position where it projects in a second direction, opposite to the first direction, characterized in that the second tool is pivoted to the head to rotate about an axis of tilt transverse to the longitudinal orientation to move from the first position to a second position, corresponding to a second operating configuration of the head and tilted upside down relative to the first position, to project in the first direction, wherein the first and second directions are aligned along the same axis so that, to move from the first to the second position, the second tool performs a rotation of 180 degrees. - a head supported by the operating arm ; - a first tool and a second tool ; - the first tool is connected to the head and projects in a first direction, the first direction being directed along an orientation transverse to the longitudinal orientation; - the second tool is connected to the head and, in a first operating configuration of the head , is disposed in a first position where it projects in a second direction, opposite to the first direction,
A film formation method, comprising the steps of: forming a catalyst film on a surface of a substrate by substitution reduction plating; forming a palladium plating film as an intermediate film on the catalyst film; and forming a gold plating film as a surface film on the palladium plating film, wherein the substrate is made of copper or a copper alloy, the catalyst film is a platinum film, and the thickness of the catalyst film is 0.001 μm or more and 0.2 μm or less. forming a catalyst film on a surface of a substrate by substitution reduction plating; forming a palladium plating film as an intermediate film on the catalyst film; and forming a gold plating film as a surface film on the palladium plating film, wherein the substrate is made of copper or a copper alloy, the catalyst film is a platinum film, and the thickness of the catalyst film is 0.001 μm or more and 0.2 μm or less.
Conveyor belt for a machine for producing web material from an initial material, in particular paper or cardboard, wherein the conveyor belt on a web material side has a web material contact surface , and on a machine side has a machine contact surface , wherein a plurality of depressions for discharging liquid and particles from the initial material of the web material away from the machine contact surface are provided on the machine side in the conveyor belt , and the conveyor belt is constructed in such a manner that the latter in the region of the interior volume thereof has a reinforcement structure which is formed by a woven fabric or another fibrous material, wherein the depressions are elongate substantially in a longitudinal direction of the conveyor belt , wherein the conveyor belt is suitable for guiding by way of the latter rollers that are driven for movement, and the depressions are configured in the manner of grooves or ruts such that drive contact without slippage is enabled with the rollers of the machine contact surface that are driven for movement, and the reinforcement structure is encased by a construction material which comprises polyurethane.
A solid oral dosage form comprising 100 mg of cedazuridine, 35 mg of decitabine, and further comprising lactose monohydrate, hydroxypropyl methyl cellulose, croscarmellose sodium, colloidal silicon dioxide, and magnesium stearate, and optionally a coating, wherein the solid oral dosage form upon daily administration to a human provides plasma levels of decitabine with a 5-day AUC for decitabine that is equivalent to the 5-day AUC for a daily intravenous dose of decitabine of 20 mg/m 2 administered as a 1 h infusion, optionally wherein upon daily administration to a human the ratio of AUC for decitabine on day 2 versus day 1 is about 1.5:1 to about 2:1.
A fatty acid amide of an amino acid, or a stereoisomer or salt thereof, for use in improving bone mineral density or treating osteoporosis in a subject suffering from Prader-Willi syndrome (PWS), wherein: the fatty acid moiety is a moiety of a saturated fatty acid, mono-unsaturated fatty acid, or poly-unsaturated fatty acid, optionally substituted on at least one of its α- or β-positions by at least one group which each independently is (C 1 -C 6 )alkyl, -OR 1 , or -SR 2 ; the amino acid moiety is a moiety of an amino acid optionally substituted at its α-position by at least one group which each independently is (C 1 -C 6 )alkyl, or -OR 3 ; and Ri, R 2 , and R 3 each independently is H or (C 1 -C 6 )alkyl, provided that at least one of the fatty acid moiety and the amino acid moiety is substituted. the fatty acid moiety is a moiety of a saturated fatty acid, mono-unsaturated fatty acid, or poly-unsaturated fatty acid, optionally substituted on at least one of its α- or β-positions by at least one group which each independently is (C 1 -C 6 )alkyl, -OR 1 , or -SR 2 ; the amino acid moiety is a moiety of an amino acid optionally substituted at its α-position by at least one group which each independently is (C 1 -C 6 )alkyl, or -OR 3 ; and Ri, R 2 , and R 3 each independently is H or (C 1 -C 6 )alkyl, provided that at least one of the fatty acid moiety and the amino acid moiety is substituted.
A closure device , comprising a first closure part and a second closure part which can be attached to each other along a closing direction (X), are held at each other in a closed position, and can be released from each other for opening the closure device , wherein the second closure part includes a housing element with a bearing opening and a rotary element rotatably mounted in the bearing opening of the housing element , wherein the rotary element is operatively connected to an actuator element and can be rotated relative to the second closure part for adjusting the actuator element along a winding direction (V), wherein the first closure part includes a first toothing device and the second closure part includes a second toothing device , and in the closed position of the closure device the first toothing device and the second toothing device are in engagement with each other in such a way that the first closure part and the second closure part are positively held relative to each other along the winding direction (V), wherein the first closure part and the second closure part each include at least one magnetic element for providing a force of magnetic attraction on attachment of the closure parts to each other.
A positive electrode active material for a lithium ion battery which is represented by the following composition formula: Li(Li x Ni 1-x-y M y )O 2+α (in the formula, M represents Mn and Co, 0 ≤ x ≤ 0.1, 0 < y ≤ 0.7, and α > 0.1), wherein a ratio of peak strength (Ps104) on plane to peak strength (Ps003) on plane, which is (Ps104/Ps003), is 0.9 or less and 2θ of plane is 64.6° or more according to powder X-ray diffraction using CuKα radiation.
A cellulose fiber molded product comprising cellulose fibers as a main component, wherein the cellulose fibers comprise pulp and defibrated fibers, and the defibrated fibers comprise microfibrillated cellulose, wherein the defibrated fibers comprise, in addition to the microfibrillated cellulose, cellulose nanofibers as a complementary material to the microfibrillated cellulose, wherein the pulp has an average fiber diameter of 10 to 100 μm, the microfibrillated cellulose has an average fiber diameter of 0.1 to 10 μm, and the cellulose nanofibers have an average fiber diameter of 10 to 100 nm, and a content percentage of the pulp in the cellulose fibers is 5 to 20% by mass. cellulose fibers as a main component, wherein the cellulose fibers comprise pulp and defibrated fibers, and the defibrated fibers comprise microfibrillated cellulose, wherein the defibrated fibers comprise, in addition to the microfibrillated cellulose, cellulose nanofibers as a complementary material to the microfibrillated cellulose, wherein the pulp has an average fiber diameter of 10 to 100 μm, the microfibrillated cellulose has an average fiber diameter of 0.1 to 10 μm, and the cellulose nanofibers have an average fiber diameter of 10 to 100 nm, and a content percentage of the pulp in the cellulose fibers is 5 to 20% by mass.
A compound of Formula (I) or a pharmaceutically acceptable salt or solvate thereof for use in a method of prevention and/or treatment of a fibrosis disease in a subject, wherein R 1 is halogen; each R 2 is the same or different, representing H, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, NH 2 , NO 2 , C 1-10 alkyloxy, C 1-10 alkylthio, C 1-10 alkylamino, C 1-10 alkyloxyC 1-10 alkyl, OH or CN, C 6-10 aryl or C 5-7 heterocyclic having 1 to 3 heteroatoms selected from the group consisting of N, O and S; R 3 is H; R 4 is H; R 5 is OH; C 3-8 cycloalkyl; phenyl unsubstituted or substituted with one to three same or different substituents selected from OH, CN, halogen, NH 2 or C 1-4 alkylpiperazinyl; C 1-6 alkylpiperazinyl; C 1-6 alkylpyridinyl; C 1-6 alkylpyrrolidinyl; pyridinyl; pyrimidinyl; pyrazinyl; piperazinyl; pyrrolidinyl; thiazolyl; benzimidazolyl; pyrazolyl; indazolyl; pyrazolyl; quinolinyl; indolyl; C 1-4 indolyl; indazolyl; azaindolyl; azaindazolyl; deazapurinyl; indanyl; morpholinoyl or C 1-4 alkylmorpholinoyl, each of which is unsubstituted or substituted with one, two or three groups selected from OH, CN, halogen or NH 2 ; or R 5 is alkylene-R 6 wherein R 6 is NR a R b , C 5-7 heterocyclic ring having 0 to 3 hetero atoms selected from O, N and S; or C 10-12 fused heterocyclic ring having 0 to 3 hetero atoms selected from O, N and S; and R a and R b are alkyl; and X is -C(O); m is 0; and n is an integer of 1-4; wherein the fibrosis disease is skin fibrosis, lung fibrosis, renal fibrosis, intestinal fibrosis, cystic fibrosis, cardiac fibrosis, uterine leiomyoma or adenomyosis. R 1 is halogen; each R 2 is the same or different, representing H, C 1-10 alkyl, C 2-10 alkenyl, C 2-10 alkynyl, NH 2 , NO 2 , C 1-10 alkyloxy, C 1-10 alkylthio, C 1-10 alkylamino, C 1-10 alkyloxyC 1-10 alkyl, OH or CN, C 6-10 aryl or C 5-7 heterocyclic having 1 to 3 heteroatoms selected from the group consisting of N, O and S; R 3 is H; R 4 is H; R 5 is OH; C 3-8 cycloalkyl; phenyl unsubstituted or substituted with one to three same or different substituents selected from OH, CN, halogen, NH 2 or C 1-4 alkylpiperazinyl; C 1-6 alkylpiperazinyl; C 1-6 alkylpyridinyl; C 1-6 alkylpyrrolidinyl; pyridinyl; pyrimidinyl; pyrazinyl; piperazinyl; pyrrolidinyl; thiazolyl; benzimidazolyl; pyrazolyl; indazolyl; pyrazolyl; quinolinyl; indolyl; C 1-4 indolyl; indazolyl; azaindolyl; azaindazolyl; deazapurinyl; indanyl; morpholinoyl or C 1-4 alkylmorpholinoyl, each of which is unsubstituted or substituted with one, two or three groups selected from OH, CN, halogen or NH 2 ; or R 5 is alkylene-R 6 wherein R 6 is NR a R b , C 5-7 heterocyclic ring having 0 to 3 hetero atoms selected from O, N and S; or C 10-12 fused heterocyclic ring having 0 to 3 hetero atoms selected from O, N and S; and R a and R b are alkyl; and X is -C(O); m is 0; and n is an integer of 1-4; wherein the fibrosis disease is skin fibrosis, lung fibrosis, renal fibrosis, intestinal fibrosis, cystic fibrosis, cardiac fibrosis, uterine leiomyoma or adenomyosis.
A media rotation mechanism comprising: a housing defining a first opening and a second opening located at an angle relative to the first opening; a media receiver defining a media receiver opening, the media receiver, the first opening, and the second opening defining a non-linear travel path for a media object through the angle; a rotation motor operative to rotate the media receiver through the angle between a first position and a second position, the first position corresponding to the media receiver opening facing the first opening, the second position corresponding to the media receiver opening facing the second opening characterized in that a turntable is mechanically coupled to the rotation motor and the media receiver . a housing defining a first opening and a second opening located at an angle relative to the first opening; a media receiver defining a media receiver opening, the media receiver, the first opening, and the second opening defining a non-linear travel path for a media object through the angle; a rotation motor operative to rotate the media receiver through the angle between a first position and a second position, the first position corresponding to the media receiver opening facing the first opening, the second position corresponding to the media receiver opening facing the second opening
Pneumatic vehicle tire which comprises a sealant layer at least on the inner surface opposite the tread , wherein the sealant layer has a radially inward-facing surface running in the axial direction substantially parallel to the belt package, characterized in that the sealant layer comprises at least one luminescent agent on its radially inward-facing surface .
A support apparatus configured to be placed on a mattress and configured to support a person , the support apparatus comprising: a top surface including one or more predetermined areas ; one or more conduits located inside the support apparatus, a portion of the one or more conduits being located proximate to the one or more predetermined areas ; and an air supply configured to provide air to the one or more conduits for delivering to the one or more predetermined areas , the air supply comprising: a temperature sensor configured to measure a temperature of the air provided by the air supply; a cooling element ; and a controller communicatively coupled to the temperature sensor and the cooling element , the controller comprising at least one processor and at least one memory storing computer readable and executable instructions that, when executed by the processor , cause the controller to: determine whether the measured temperature of the air is higher than a predetermined temperature; and control the cooling element to cool the air to the predetermined temperature if it is determined that the temperature of the air is higher than the predetermined temperature. a top surface including one or more predetermined areas ; one or more conduits located inside the support apparatus, a portion of the one or more conduits being located proximate to the one or more predetermined areas ; and an air supply configured to provide air to the one or more conduits for delivering to the one or more predetermined areas , the air supply comprising: a temperature sensor configured to measure a temperature of the air provided by the air supply; a cooling element ; and a controller communicatively coupled to the temperature sensor and the cooling element , the controller comprising at least one processor and at least one memory storing computer readable and executable instructions that, when executed by the processor , cause the controller to: determine whether the measured temperature of the air is higher than a predetermined temperature; and control the cooling element to cool the air to the predetermined temperature if it is determined that the temperature of the air is higher than the predetermined temperature. a temperature sensor configured to measure a temperature of the air provided by the air supply; a cooling element ; and a controller communicatively coupled to the temperature sensor and the cooling element , the controller comprising at least one processor and at least one memory storing computer readable and executable instructions that, when executed by the processor , cause the controller to: determine whether the measured temperature of the air is higher than a predetermined temperature; and control the cooling element to cool the air to the predetermined temperature if it is determined that the temperature of the air is higher than the predetermined temperature. determine whether the measured temperature of the air is higher than a predetermined temperature; and control the cooling element to cool the air to the predetermined temperature if it is determined that the temperature of the air is higher than the predetermined temperature.
Cosmetic lipid mixture consisting of a) octyldodecanol and b) hydrogenated rapeseed oil in a weight ratio of 7:1 to 1:1, wherein the hydrogenated rapeseed oil has a behenic acid content of 35-60% by weight based on the total weight of the hydrogenated rapeseed oil. a) octyldodecanol and b) hydrogenated rapeseed oil in a weight ratio of 7:1 to 1:1, wherein the hydrogenated rapeseed oil has a behenic acid content of 35-60% by weight based on the total weight of the hydrogenated rapeseed oil.
A method for analyzing a tissue sample, the method comprising: orienting a tissue sample in a tissue chamber in a desired position; exposing the tissue sample to a first solution for chemical processing in the desired position in the tissue chamber; immersing the chemically processed tissue sample in a fluid in the desired position in the tissue chamber; and imaging the immersed tissue sample in the desired position in the tissue chamber without repositioning the tissue sample after orienting. orienting a tissue sample in a tissue chamber in a desired position; exposing the tissue sample to a first solution for chemical processing in the desired position in the tissue chamber; immersing the chemically processed tissue sample in a fluid in the desired position in the tissue chamber; and imaging the immersed tissue sample in the desired position in the tissue chamber without repositioning the tissue sample after orienting.
A system comprising: a mobile smartphone device ; and a medicament-free device , the medicament-free device being a medicament dispenser not containing medicament, the medicament-free device comprising: a sensing device configured to sense a user action performed upon the medicament-free device and to output sensed data, wherein the sensing device comprises an acoustic sensor; a wireless communications device configured to communicate to the mobile smartphone device ; and a processor configured to: receive the sensed data from the sensing device ; compare the sensed data with predefined data indicative of a model user action associated with the medicament-free device ; and provide feedback based on how the sensed data is compared to the predefined data, the feedback being provided to the user via the wireless communications device , wherein the mobile smartphone device is configured to receive the feedback and, in response to the received feedback, display a representation of the sensed user action. a mobile smartphone device ; and a medicament-free device , the medicament-free device being a medicament dispenser not containing medicament, the medicament-free device comprising: a sensing device configured to sense a user action performed upon the medicament-free device and to output sensed data, wherein the sensing device comprises an acoustic sensor; a wireless communications device configured to communicate to the mobile smartphone device ; and a processor configured to: receive the sensed data from the sensing device ; compare the sensed data with predefined data indicative of a model user action associated with the medicament-free device ; and provide feedback based on how the sensed data is compared to the predefined data, the feedback being provided to the user via the wireless communications device , wherein the mobile smartphone device is configured to receive the feedback and, in response to the received feedback, display a representation of the sensed user action. a sensing device configured to sense a user action performed upon the medicament-free device and to output sensed data, wherein the sensing device comprises an acoustic sensor; a wireless communications device configured to communicate to the mobile smartphone device ; and a processor configured to: receive the sensed data from the sensing device ; compare the sensed data with predefined data indicative of a model user action associated with the medicament-free device ; and provide feedback based on how the sensed data is compared to the predefined data, the feedback being provided to the user via the wireless communications device , receive the sensed data from the sensing device ; compare the sensed data with predefined data indicative of a model user action associated with the medicament-free device ; and provide feedback based on how the sensed data is compared to the predefined data, the feedback being provided to the user via the wireless communications device , wherein the mobile smartphone device is configured to receive the feedback and, in response to the received feedback, display a representation of the sensed user action.
A switch rod for switching at least one valve train component in an internal combustion engine, having a base body and having a plurality of functional elements for transmitting a thrust force for switching, characterised in that the base body is produced from plastic by injection moulding and the functional elements are each produced from metal and are partially overmoulded with plastic for a fixed connection to the base body .
Self-propelled material processing and/or handling system for processing and/or handling construction and/or raw materials, in particular a crushing system, with at least one working unit which is drivable by an electric unit drive with an electric motor (EM), as well as at least one electric travel drive with an electric motor (EM), as well as a control device for controlling the electric motors (EM) of the unit and travel drives , characterized in that the control device comprises a common frequency converter for the travel drive and the unit drive and provides various parameter sets for the common frequency converter , so that the travel drive is actuatable by the frequency converter on the basis of a first parameter set and the unit drive is actuatable on the basis of a second parameter set .